Ancient Plague, Cyclical Pandemics…History Lesson?

Even the plague wanted to visit Stonehenge We’re about to blow your mind: The history you learned in school was often inaccurate. Shocking, we know, so we’ll give you a minute to process this incredible news. Better? Good. Now, let’s look back at high school European history. The Black Death, specifically. The common narrative is

Walmart Is Raising Wages for Pharmacists, Opticians

BENTONVILLE, Ark. (Reuters) – Walmart is raising wages for thousands of U.S. pharmacists and opticians, the retailer said on Wednesday, part of its broader plan to expand primary care services across the country. The Bentonville, Arkansas-based chain said about 3,700 pharmacists would get a bump in pay starting on Wednesday, bringing their total annual average

First IL-17 Inhibitor Approved in Europe for HS Patients

The European Commission has approved secukinumab (Cosentyx) as a treatment for adults with active, moderate to severe hidradenitis suppurativa (HS) that didn’t respond to conventional therapy. The biologic is the first interleukin-17A (IL-17A) inhibitor to be approved for the treatment of moderate to severe HS. The manufacturer, Novartis, expects a regulatory decision from the US

Lupus Nephritis: Hopes, Questions Arise for Baricitinib

MILAN, Italy — The oral Janus kinase (JAK) 1/2 inhibitor baricitinib (Olumiant) demonstrated significantly better efficacy than cyclophosphamide infusions in the treatment of lupus nephritis in a small, independently funded, phase 3, double-blind clinical trial, Manal Hassanien, MD, reported at the European Alliance of Associations for Rheumatology (EULAR) 2023 Annual Meeting. Baricitinib, licensed by Eli